INFECTIOUS DISEASES: vaginal multipurpose prevention technologies for HIV and STIs; novel antibacterial compounds and formulations for resistant pathogens in human and veterinary applications.
NANOMEDICINE and ANTICANCER DRUG DELIVERY: local and systemic tumour targetting, applications of nanoscience to drug development
TRANSLATIONAL DRUG DEVELOPMENT (human and veterinary): preformulation, physico-chemical characterization, solubility and stability assessment and improvement, data for regulatory submissions.
CONVENTIONAL AND NOVEL DELIVERY SYSTEMS (human and veterinary): patentable non-infringing platform technologies: nanotechnology, solid, semisolid and liquid dosage forms; reverse engineering.
PHARMACEUTICAL ANALYSIS, QUALITY CONTROL, AND REGULATION: analysis of drugs, metabolites and excipients in the pure form, formulations; stability indicating analytical method development and validation; Good Laboratory Practices (GLP); Good Manufacturing Practice (GMP); pharmaceutical quality assurance and control (QA and QC); regulatory documentation; registration dossier preparation and evaluation; Intellectual Property (IP) issues.
COSMETICS, HERBALS, PROBIOTICS, and COMPLEMENTARY MEDICINES
INDEPENDENT CONSULTING in all of the above areas, pharmaceutical expert for patent and regulatory issues
